tirzepatide jay campbell Tirzepatide vs. Semaglutide for Patients with Obesity: A Head-to-Head Trial https The Jay Campbell Podcast |

This shift improves access to care and reduces stigma around pharmaceutical intervention

Call (248) 557-1688 or contact online to discuss your situation

+The benefit-risk balance remains in favour of using semaglutide for its approved indications (diabetes, obesity) for most patientsbut the ocular risk is something to monitor, especially in high-risk eyes

lifestyle matters more than the peptide itself

These compounds collectively provide researchers with tools for investigating incretin receptor biology, metabolic signaling integration, and endocrine pathway regulation

While GLP-1s can be more effective than lifestyle changes alone, including changes to your diet and increasing physical activity, its worth noting that the best approach to using GLP-1s is to combine them with those healthy habits